Patricia Carr sold $456K of Jazz Pharmaceuticals (JAZZ)

Executed Feb 26, disclosed Mar 2, 4 days later.

Value, as filed

$456K

2,370 sh across 2 lots

Executed

Feb 26

the trade date, as filed

Disclosed

Mar 2

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Patricia Carr SVP, Chief Accounting Officer profile →

Patricia Carr (SVP, Chief Accounting Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Jazz Pharmaceuticals plc (JAZZ). The largest single filing was $956K of JAZZ (5,250 sh × $182.07, as filed), executed Nov 18 2025.

The name

JAZZ

Jazz Pharmaceuticals plc JAZZ · Healthcare · 50 filings in 24 months ticker →

Healthcare · Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Patricia Carr in JAZZ

JAZZSALE Jazz Pharmaceuticals plc $289K
1,250 sh × $231.37
Exec Nov 4
Filed Nov 6 · 5:19 PM ET JAZZSALE Jazz Pharmaceuticals plc $235K
1,287 sh × $182.94
Exec Mar 9
Filed Mar 9 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $770K
4,500 sh × $171.20
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $956K
5,250 sh × $182.07
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $157K
1,140 sh × $137.81
Exec Mar 10 2025
Filed Mar 11 2025 · 5:30 PM ET JAZZSALE Jazz Pharmaceuticals plc $761K
5,273 sh across 2 lots
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET